Sumitomo Mitsui Trust Holdings, Inc. Moderna, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $138 Billion
- Q1 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 751,804 shares of MRNA stock, worth $25.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
751,804
Previous 755,691
0.51%
Holding current value
$25.5 Million
Previous $31.4 Million
32.17%
% of portfolio
0.02%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding MRNA
# of Institutions
859Shares Held
255MCall Options Held
23.9MPut Options Held
30.2M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.37 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$867 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$846 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$603 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$253 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.3B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...